CIPOLLO Byos license

The Food and Drug Administration has forecasted a software license agreement for CIPOLLO Byos, a specialized mass spectrometry data analysis platform, to support scientific and regulatory operations. The procurement is classified under NAICS code 511210 for software publishing and is intended to enhance data processing capabilities critical to the agency's mission in evaluating biological and pharmaceutical products. The license will enable authorized users to analyze complex spectral datasets with precision and efficiency, directly supporting research and compliance activities within the agency’s Center for Biologics Evaluation and Research. All contract inquiries and communications shall be directed to the Cber Acquisition Liaison at cberacquisitions@fda.hhs.gov, while the contracting officer position remains to be determined. The forecast was posted on May 25, 2026, and no set-aside classification or specific place of performance has been designated at this stage. No solicitation number has yet been assigned, indicating the opportunity is still in the planning phase. Stakeholders are encouraged to monitor the official HHS OSDBU portal for updates on the formal solicitation process, which will follow this forecast and likely include detailed technical requirements and delivery terms.